Cargando…

Immunohistochemical Monitoring of Wound Healing in Antibiotic Treated Buruli Ulcer Patients

BACKGROUND: While traditionally surgery has dominated the clinical management of Buruli ulcer (BU), the introduction of the combination chemotherapy with oral rifampicin and intramuscular streptomycin greatly improved treatment and reduced recurrence rates. However management of the often extensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreoli, Arianna, Ruf, Marie-Thérèse, Sopoh, Ghislain Emmanuel, Schmid, Peter, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998920/ https://www.ncbi.nlm.nih.gov/pubmed/24762629 http://dx.doi.org/10.1371/journal.pntd.0002809

Ejemplares similares

Histopathological Changes and Clinical Responses of Buruli Ulcer Plaque Lesions during Chemotherapy: A Role for Surgical Removal of Necrotic Tissue?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria
por: Ruf, Marie-Thérèse, et al.
Publicado: (2017)

Buruli Ulcer, Nigeria
por: Chukwuekezie, Okechukwu, et al.
Publicado: (2007)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Buruli Ulcer Distribution in Benin
por: Johnson, Roch Christian, et al.
Publicado: (2005)

Complete Healing of a Laboratory-Confirmed Buruli Ulcer Lesion after Receiving Only Herbal Household Remedies
por: Andreoli, Arianna, et al.
Publicado: (2015)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Buruli Ulcer Surveillance, Benin, 2003–2005
por: Sopoh, Ghislain Emmanuel, et al.
Publicado: (2007)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Buruli Ulcer Prevalence and Altitude, Benin
por: Sopoh, Ghislain Emmanuel, et al.
Publicado: (2011)

Towards Rational Use of Antibiotics for Suspected Secondary Infections in Buruli Ulcer Patients
por: Barogui, Yves T., et al.
Publicado: (2013)

Family Relationship, Water Contact and Occurrence of Buruli Ulcer in Benin
por: Sopoh, Ghislain Emmanuel, et al.
Publicado: (2010)

Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital
por: Please, Helen R., et al.
Publicado: (2021)

Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment
por: Scherr, Nicole, et al.
Publicado: (2015)

The gendered impact of Buruli ulcer on the household production of health and social support networks: Why decentralization favors women
por: Agbo, Ines Elvire, et al.
Publicado: (2019)

Improving clinical and epidemiological predictors of Buruli ulcer
por: Ayelo, Gilbert Adjimon, et al.
Publicado: (2018)

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana
por: Addison, Naa Okaikor, et al.
Publicado: (2017)

Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin
por: Alferink, Marike, et al.
Publicado: (2015)

Assessment and Treatment of Pain during Treatment of Buruli Ulcer
por: de Zeeuw, Janine, et al.
Publicado: (2015)

Development of Highly Organized Lymphoid Structures in Buruli Ulcer Lesions after Treatment with Rifampicin and Streptomycin
por: Schütte, Daniela, et al.
Publicado: (2007)

Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2013)

Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions
por: Ogbechi, Joy, et al.
Publicado: (2015)

Contribution of the Community Health Volunteers in the Control of Buruli Ulcer in Bénin
por: Barogui, Yves Thierry, et al.
Publicado: (2014)

Genetic Variation in Autophagy-Related Genes Influences the Risk and Phenotype of Buruli Ulcer
por: Capela, Carlos, et al.
Publicado: (2016)

Detection of Mycobacterium ulcerans in the Environment Predicts Prevalence of Buruli Ulcer in Benin
por: Williamson, Heather R., et al.
Publicado: (2012)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Bénin (West Africa)
por: Anagonou, Esaï Gimatal, et al.
Publicado: (2019)

Spatial Analysis of Anthropogenic Landscape Disturbance and Buruli Ulcer Disease in Benin
por: Campbell, Lindsay P., et al.
Publicado: (2015)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Single Nucleotide Polymorphism Typing of Mycobacterium ulcerans Reveals Focal Transmission of Buruli Ulcer in a Highly Endemic Region of Ghana
por: Röltgen, Katharina, et al.
Publicado: (2010)

Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial
por: Vogel, Moritz, et al.
Publicado: (2016)

Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016
por: Ayelo, Gilbert Adjimon, et al.
Publicado: (2018)

Buruli Ulcer in Cameroon: The Development and Impact of the National Control Programme
por: Tabah, Earnest Njih, et al.
Publicado: (2016)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Genetic variants in human BCL2L11 (BIM) are associated with ulcerative forms of Buruli ulcer
por: Fevereiro, João, et al.
Publicado: (2021)

Assessment of water, sanitation, and hygiene practices and associated factors in a Buruli ulcer endemic district in Benin (West Africa)
por: Johnson, Roch Christian, et al.
Publicado: (2015)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dk3mige7mgljg93skcmp454k9u